We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.7B
AUM Growth
-$3.96B
Cap. Flow
-$1.66B
Cap. Flow %
-13.11%
Top 10 Hldgs %
14.02%
Holding
2,200
New
84
Increased
771
Reduced
1,166
Closed
158
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PENN icon
1276
PENN Entertainment
PENN
$2.71B
$902K 0.01%
29,653
-9,711
-25% -$328K
UL icon
1277
Unilever
UL
$136B
$900K 0.01%
17,462
-2,984
-15% -$152K
UMPQ
1278
DELISTED
Umpqua Holdings Corp
UMPQ
$899K 0.01%
53,608
-9,688
-15% -$168K
EXK
1279
Endeavour Silver
EXK
$2.83B
$892K 0.01%
283,924
+54,665
+24% +$216K
PACW
1280
DELISTED
PacWest Bancorp
PACW
$889K 0.01%
33,336
-1,480
-4% -$47.9K
OPEN icon
1281
Opendoor
OPEN
$3.38B
$888K 0.01%
194,770
-48,795
-20% -$322K
EDF
1282
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$171M
$884K 0.01%
200,853
+21,750
+12% +$119K
SNY icon
1283
Sanofi
SNY
$104B
$884K 0.01%
17,659
-10,445
-37% -$554K
TD icon
1284
Toronto Dominion Bank
TD
$200B
$882K 0.01%
13,459
+8,804
+189% +$639K
LSXMK
1285
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$876K 0.01%
31,371
+13,297
+74% +$419K
DFP
1286
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$427M
$873K 0.01%
40,624
+12,282
+43% +$284K
EGRX
1287
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$873K 0.01%
19,655
+1,923
+11% +$88.3K
CLB icon
1288
Core Laboratories
CLB
$521M
$864K 0.01%
43,617
+19,251
+79% +$511K
TYL icon
1289
Tyler Technologies
TYL
$12.8B
$862K 0.01%
2,591
-2,182
-46% -$799K
BCPC
1290
Balchem Corp
BCPC
$5.72B
$862K 0.01%
6,640
+630
+10% +$78.8K
BLD
1291
DELISTED
TopBuild
BLD
$859K 0.01%
5,137
+165
+3% +$30.2K
VVV icon
1292
Valvoline
VVV
$4.51B
$859K 0.01%
29,789
-27,952
-48% -$859K
WIRE
1293
DELISTED
Encore Wire Corp
WIRE
$859K 0.01%
8,269
-214
-3% -$25.3K
BRO icon
1294
Brown & Brown
BRO
$23.9B
$857K 0.01%
14,680
-16,633
-53% -$1.02M
SMG icon
1295
ScottsMiracle-Gro
SMG
$3.66B
$855K 0.01%
10,833
-1,754
-14% -$173K
LFC
1296
DELISTED
China Life Insurance Company Ltd.
LFC
$854K 0.01%
98,927
+12,878
+15% +$98.1K
VBF icon
1297
Invesco Bond Fund
VBF
$169M
$852K 0.01%
52,401
-16,281
-24% -$264K
UFPI icon
1298
UFP Industries
UFPI
$5.19B
$849K 0.01%
12,455
-3,416
-22% -$257K
NE icon
1299
Noble Corp
NE
$6.51B
$847K 0.01%
33,419
+8,861
+36% +$292K
ALE
1300
DELISTED
Allete
ALE
$846K 0.01%
14,387
+2,072
+17% +$127K

Similar funds

Guggenheim Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Guggenheim Capital held 2,200 positions worth $12.7B, down 24% from $16.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Guggenheim Capital withdrew a net $1.66B in Q2 2022, closing 158 positions and reducing 1,166 holdings. Its most notable exit was BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in ESAB worth $3.14M.

  • Guggenheim Capital's largest Q2 2022 buy was ESAB: 71,750 shares worth $3.14M.
  • Guggenheim Capital added most to Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q2 2022, an estimated $25.1M increase.
  • Guggenheim Capital's biggest Q2 2022 reduction was Apple, cutting an estimated $68.5M.
  • Guggenheim Capital fully exited BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC in Q2 2022, selling an estimated $13.1M.
  • Guggenheim Capital's ten largest holdings make up 14% of its $12.7B portfolio in Q2 2022.
  • Guggenheim Capital opened 84 new positions and closed 158 in Q2 2022.
  • Guggenheim Capital's portfolio value fell 24% quarter-over-quarter to $12.7B.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.